NEO
Neogenomics·NASDAQ
--
--(--)
--
--(--)
5.50 / 10
Netural
Liquidity flow evaluation: 7.43/10 demonstrating robust fund flow characteristics. Optimistic overall, block, Small, Medium, Large, and Extra-large patterns are mitigated by pessimistic no significant trends indicators, pointing to positive flow perspective. Professional analyst opinion suggests overwhelmingly bullish analyst consensus, showing strong conviction. Distribution pattern: Strong Buy(100.0%) based on 1 research evaluations, supported by 3.58 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-12
InstitutionNeedham
Times predicted5
Historical Win Rate40.0%
What is the market sentiment for NEO?
- NEO holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.50/10 (Netural).
